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Abstract Cells isolated from intervertebral disc
(IVD) tissues of human surgical samples are one of
potential sources for the IVD cellular therapy. The
purpose of this study was to develop a new non-
enzymatic method, ‘‘tissue incubation’’, for isolating
human IVD cells. The IVD tissues of annulus fibrosus
(AF) and nucleus pulposus (NP) were incubated
separately in tissue culture flasks with culture medium.
After 7–10 days incubation, cells were able to migrate
out of IVD tissues and proliferate in vitro. After
3–4 weeks culture, expanded cells were harvested by
trypsinization, and the remaining tissues were trans-
ferred to a new flask for another round of incubation.
The molecular phenotype of IVD cells from juvenile
and adult human samples was evaluated by both flow
cytometry analysis and immunocytochemical staining
for the expression of protein markers of NP cells
(CD24, CD54, CD239, integrin a6 and laminin a5).
Flow cytometry confirmed that both AF and NP cells
of all ages positively expressed CD54 and integrin a6,
with higher expression levels in NP cells than in AF
cells for the juvenile group sample. However, CD24
expression was only found in juvenile NP cells, and
not in AF or older disc cells. Similar expression
patterns for NP markers were also confirmed by
immunocytochemistry. In summary, this new non-
enzymatic tissue incubation method for cell isolation
preserves molecular phenotypic markers of NP cells
and may provide a valuable cell source for the study of
NP regeneration strategies.
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Introduction
The intervertebral disc (IVD) is the largest avascular
structure in the body and is composed of three
morphologically distinct regions, the central nucleus
pulposus (NP), the peripheral annulus fibrosus (AF),
and the cartilaginous endplates. Disc degeneration is
considered to be one of the major causes of low back
pain, and characterized by dysfunctional cells along
with the loss of morphological distinction between
regions and extracellular matrix production (Freemont
2009; Urban and Roberts 2003), which ultimately
disrupts the finely balanced biomechanics of the disc
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and spine as a whole (Urban and McMullin 1985;
Butler et al. 1990).
Due to a decline of cellularity and potentially a
change in cell phenotype with age, the IVD exhibits a
very limited capability for self-repair (Smith and
Walmsley 1951; Melrose et al. 1992; Zhao et al.
2007). Recently, cell therapy has been used as a
strategy to regenerate disc structure and restore disc
function (Sakai et al. 2005; Smith et al. 2011; Risbud
et al. 2004), and there is significant interest in
developing strategies to repopulate the degenerated
disc using an appropriate cell source, with work
investigating bone marrow-derived mesenchymal
stem cells (MSCs), allogeneic chondrocytes and
autologous disc cells as potential candidates for NP
cell therapies (Sakai et al. 2003; Ganey et al. 2003;
Huang et al. 2013; Acosta et al. 2011; McCanless et al.
2011; Yoshikawa et al. 2010; Gruber et al. 2002). A
potential cell source for autologous transplantation
also includes human disc cells from tissue surgical
samples from discectomy procedure. The standard
approach for isolating cells from IVD tissue involves
enzymatic digestion via pronase and collagenase
treatment (Wang et al. 2001; Chen et al. 2002; 2004;
Gilchrist et al. 2007; Gabr et al. 2011). However, it is a
challenge to isolate disc cells via traditional enzymatic
methods because the cells populating human IVD
tissues are sparsely distributed and embedded within a
very dense extracellular matrix (i.e. collagen and
proteoglycan) network. In order to obtain sufficient
cell numbers, large amounts of tissue are typically
needed (usually pooled from multiple disc levels).
Additionally, cells isolated via enzymatic digestion
may suffer damage to cell surface receptors immedi-
ately upon isolation (Gilchrist et al. 2007), require
longer expansion time to recover, and need multiple
passages to achieve sufficient cell numbers, with
increased passages and longer expansion resulting in
cell dedifferentiation (Wang et al. 2001). To overcome
these disadvantages, we have developed a new non-
enzymatic method, ‘‘tissue incubation’’, for isolating
disc cells. In this study, we use this method to isolate
cells from IVD tissues and examine whether NP cell
phenotype is preserved, utilizing NP phenotypic
markers (CD24, CD54, CD239, laminin a5 and
integrin a6) previously validated in our lab (Gilchrist
et al. 2007; Gabr et al. 2011; Chen et al. 2006; 2009;
Tang et al. 2012). Our findings suggest that this
method is effective for isolating phenotypically
distinct NP cells for in vitro investigations of disc cell
biology and their application in cell-based regenera-
tive medicine.
Materials and methods
IVD tissue isolation and incubation
Human lumbar IVD tissues (to-be-discarded surgical
waste, approved from review by the Duke University
Institutional Review Board) were obtained from
patients undergoing surgery for degenerative disc
disease (total n = 4 patients, age 39–71 years old) or
scoliosis (total n = 4 patients, age 6–21 years old).
Tissues were anonymized, with only data for patient
age, gender and race were recorded. Disc tissues were
rinsed with PBS (EMD Chemicals, Gibbstown, NJ,
USA) and grossly separated into AF and nucleus NP
according to the anatomic appearance (Gabr et al.
2011). Any other non-disc materials such as endplate
bone or cartilage in the surgical sample were discarded
prior to tissue incubation. Separated AF and NP tissues
were further washed with washing medium (DMEM
basal medium with 100 lg/ml kanamycin (Sigma, St.
Louis, MO, USA) and 165 lg/ml gentamycin (Gibco,
Grand Island, NY, USA), 1.25 lg/ml fungizone
(Gibco) three times and cut into small pieces (average
size of the tissue explant is 1–2 mm3 for AF, 3–5 mm3
for NP), then placed in culture medium (F12, Invit-
rogen Life Technologies, Carlsbad, CA, USA) sup-
plemented with 10 % FBS (Hyclone, South Logan,
Utah, USA) in 25-cm2 flask coated with 0.1 % gelatin
(Sigma) at 37 C, 5 % CO2 condition. Culture
medium was changed every 2 days. Once cells had
migrated out of tissue and expanded for 3–4 weeks (to
about 80 % of confluence), tissue explants were
transferred into a new flask for another round of
incubation, with remaining cells in the original flask
ready for harvesting (see the outline of this method in
Fig. 1). In general, incubated tissues can be transferred
up to 10 times or until no more cells migrated out.
Cell harvesting and flow cytometry
Following tissue incubation, disc cells were detached
from the culture surface using 0.025 % Trypsin/
EDTA (Lonza, Basel, Switzerland) for a very short
period of time (\3 min). Total cell number in each
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flask was counted by the trypan blue assay. The
trypsinized cells were allowed to recover in culture
medium (F12 medium with 10 % FBS) for 30 min at
37 C before flow cytometry analysis in order to
minimize the possible damage of cell surface receptors
due to trypsin. Cells (0.2–0.5 9 106) were then
incubated with anti-human antibodies for NP markers
(CD24, CD54 and integrin a6, see Table 1) and
appropriate isotype controls (mouse or rat IgG,
Table 1) for 30 min. Cells were washed twice in
PBS and then incubated with appropriate AlexaFluor
488-conjugated secondary antibodies (Invitrogen,
Eugene, OR, USA) for 30 min. The percentage of
positive cells (%) and mean fluorescence intensity
(MFI) for each marker protein were analyzed by flow
cytometry (Accuri C6, BD Accuri Cytometers Inc.,
Ann Arbor, MI, USA).
Immunocytochemical staining
In order to assess expression of NP markers in human
disc cells under monolayer culture conditions, NP and
AF cells were trypsinized and seeded onto 8-well
chamber slides (Nalge Nunc, Rochester, NY, USA,
Fig. 1 Schematic of human
IVD cell isolation via the
tissue incubation method.
A Morphology of AF and
NP tissues from IVDs of
juvenile patients.
Microscopic images of B AF
tissue and C NP tissue used
in the tissue incubation. Bar
100 lm
Table 1 Antibodies of markers for human NP cells used in flow cytometry analysis (FC ) and immunocytochemical staining (IC)
Anti-human
antibody
Order number (vendor) Host
monoclonal
Isotype control (vendor) Application
CD24 555,426 (BD Biosciences,
San Jose, CA, USA)
mouse Ms IgG2a, k (BD Biosciences) IC and FC
CD54 MCA1615GA (AbD Serotec,
Raleigh, NC, USA)
mouse Ms IgG1 (Millipore) IC and FC
CD239 3,706-1 (Epitomics, Burlingam,
CA, USA)
rabbit Rb IgG (Epitomics) IC
Laminin a5 MAB1924 (Millipore,
Billerica, MA, USA)
mouse Ms IgG2a (AbD Serotec) IC
Integrin a6 (CD49f) 555,734 (GoH3) (BD Biosciences) rat rat IgG2a (BD Biosciences) IC and FC
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20,000 cells/well) coated with 0.1 % gelatin. Cells
were incubated in culture medium overnight at 37 C
to allow for attachment, followed by fixation in 4 %
formaldehyde (Electron Microscopy Sciences, Hat-
field, PA, USA) and incubation with a blocking
solution (30 min), washing with PBS, and incubation
with anti-human antibodies for specific NP markers
(CD24, CD54, C239, laminin a5 and integrin a6, see
Table 1) for 2 h. For control sections, appropriate
mouse, rat or rabbit IgG isotype controls (Table 1)
were used. All sections were then incubated with
appropriate AlexaFluor 488-conjugated secondary
antibodies (Invitrogen) for 30 min in blocking
solution, counter-stained with propidium iodide
(0.2 mg/ml, Sigma) to label cell nuclei, and imaged
via confocal laser scanning microscopy (Zeiss LSM
510; 209 NA 0.5 and 639 NA 1.2 objectives; Carl
Zeiss, Thornwood, NY, USA).
Results
IVD cells release from tissue explants
AF and NP tissues harvested from surgical samples
generally displayed different tissue morphology and
structure. A distinct oriented collagen fiber-like
structure was observed in AF tissues (Fig. 1A, B),
while NP tissues of juvenile discs exhibited a gelat-
inous-like structure and did not have oriented collagen
fiber structure (Fig. 1A, C). After 7–10 days of
incubation, cells started to migrate out of tissues
(Fig. 1). It was observed that AF cells generally
migrated out of tissue earlier than NP cells, and that
tissue from young patients also started ‘‘releasing’’
cells earlier as compared to that of aged tissue. In all
ages, released NP cells displayed spindle morphology,
whereas released AF cells exhibited a more elongated
shape on the culture surface (Fig. 2). Generally, after
3–4 weeks of incubation, approximately 0.5 9 106
cells per flask were collected from juvenile AF and NP
disc tissue. For the adult disc tissue, however, lower
numbers of cells (AF *0.3 9 106 cells/flask, NP
*0.2 9 106 cells/flask) were collected (Table 2).
This finding of lower cell yield in aged tissue is
consistent with a previous report showing the lower
cellularity in aged IVD (Zhao et al. 2007).
NP phenotype detection by flow cytometry
To confirm the molecular phenotype of NP cells that
migrated out of tissues, we evaluated the expression of
cell surface receptors (CD24, CD54 and integrin a6)
previously reported in NP cells of rat (Tang et al.
2012), pig (Gilchrist et al. 2007) and human (Gabr
et al. 2011; Chen et al. 2009). Flow cytometry analysis
for cells from IVD samples of young (6-year old) and
aged (68-year old) patients showed CD24 was only
expressed in 6-year old NP cells while CD54 and
integrin a6 expression was found both in AF and NP
Fig. 2 Morphology of cells migrated out of IVD tissues. Left: AF cells from tissue incubation (elongated shape). Right: NP cells from
tissue incubation (spindle shape). Bar 100 lm
Table 2 Average total number of cells migrated out of human
IVD tissues after one round of tissue incubation




Cell number (9106 ± SD)
AF NP
Juvenile 5 pieces 0.5 ± 0.38 0.5 ± 0.21
Adult 5 pieces 0.3 ± 0.10 0.2 ± 0.09
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cells of both 6- and 68-year old samples (Fig. 3). NP
cells from the 6-year old sample expressed CD24 with
higher percentage of positive cells (30.9 %) and MFI
(65) as compared to that of 68-year old sample (4.6 %,
MFI 6) (Fig. 3 left). In contrast, CD24 expression was
not detected in AF cells of any age (Fig. 3 left). For
CD54 expression, NP cells from the 6-year old sample
had a higher percentage of positive cells (48.8 %) and
MFI (121) as compared to AF cells of 6-year old
(17.3 %, MFI 11) (Fig. 3 middle). However, CD54
expression levels in 68-year old AF and NP cells was
found to be similar (AF: 16.6 %, MFI 28; NP: 20.6 %,
MFI 52) (Fig. 3 middle). For integrin a6, NP cells
generally had a higher level expression than AF cells
in both young [6-year old: NP (29.6 %, MFI 85); AF
(4.7 %, MFI 29)] and old patients [68-year old: NP
(23.4 %, 276); AF (15.8 %, MFI: 98)] (Fig. 3 right).
In general, we found that both positive cell percentage
and MFI displayed the similar expression pattern as
mentioned above in all other surgical samples.
NP phenotype detection by immunocytochemistry
Immunolabeling techniques also were used to confirm
protein expression patterns for disc cells during
monolayer culture. Similar to flow cytometry findings,
immunocytochemical staining confirmed a distinct
staining pattern of NP markers in NP cells as
compared to AF cells for all samples in both juvenile
and old groups. As demonstrated in Fig. 4, NP cells
from the 6-year old sample stained intensively positive
for cell surface receptors (CD24, CD54, CD239 and
integrin a6) and NP-specific extracellular matrix,
laminin a5 (Fig. 4). However, NP cells from the
68-year old sample did not express CD24 and stained
only slightly positive for CD239 and integrin a6,
although expression of CD54 and laminin a5 were still
clearly observed (Fig. 4). In contrast, AF cells of both
ages were negative for NP markers, with the exception
of slightly positive staining for CD54 and laminin a5
in 6-year old AF cells (Fig. 4).
Discussion
Human IVD tissue is a complicated structure in which
the cells are sparsely distributed within a dense
extracellular matrix. It is a significant challenge to
isolate primary IVD cells, as isolation by traditional
enzymatic digestion often results in damage to cell
surface receptors, requiring longer times in culture for
cells to recover and multiple cell passages to achieve
sufficient cell numbers. These longer expansion times
and increased passage numbers may result in cell
dedifferentiation. In the current study, we successfully
isolated human IVD cells with distinct NP cell
phenotypes through a non-enzymatic method, termed
‘‘tissue incubation’’. This method permits successful
cell isolations from small amounts of IVD waste
tissue, including that obtained from minimally inva-
sive surgery cases where large amounts of tissue are
not available. The method also permits us to isolate
cells from individual IVD levels, making level-
specific studies possible. Furthermore, NP or AF cells
Fig. 3 Flow cytometric
analysis for NP marker
expression in IVD cells from
different ages of patients (6
and 68 year old).
Representative histograms
of flow cytometry illustrate
the relative fluorescence
intensity of protein
expression on X-axis for
migrated cells (cell surface
receptors: CD24, CD54 and
integrin a6). Black line:
isotype control, blue line:
AF cells, red line: NP cells.
The numbers appearing in
each histogram are positive-
cell percentage and MFI.
(Color figure online)
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isolated by this tissue incubation method may be
relatively pure because any monocytes or other
immune cells residuals (that possibly have infiltrated
degenerated or pathological tissue) could be washed
away by the multiple medium change processes during
the tissue incubation period. Interestingly, disc cells
can be collected continuously through transferring the
same tissue to a new culture surface many times.
According to our experience, IVD cells could be
passaged up to 5–6 times before they stop doublings
(we only used cells without passage to prevent cell
dedifferentiate in this study). Although IVD cells are
belonging to differentiated cells (as a more specialized
cell type), they still can be promoted to divide under
serum culture condition (10 % FBS) as other primary
cell culture in vitro. Importantly, recent studies have
revealed that human IVD cells may contain cells
exhibiting notochordal cell phonotypes (Chen et al.
2009; Weiler et al. 2010) and progenitor cell popula-
tion (Risbud et al. 2007; Sakai et al. 2012). This may
also explain that human IVD cells may not only
accumulate in G1 phase and probably preserve some
signature of progenitor cells which could make them
grow and multiply in vitro.
We counted the cell numbers migrating out of disc
tissues and compared cell ‘‘release’’ differences
between tissue regions (AF vs. NP) and ages (juvenile
vs. adult). NP cells were much slower to migrate out as
compared to AF cells. It is possible that this could be
related to differences in tissue attachment to the
culture surface, with soft NP tissue not attaching as
readily or completely to the flask surface as compared
to relatively hard AF tissue. Additionally, juvenile
tissues seemed to ‘‘release’’ more cells than adult
tissues, which may reflect the higher cellularity in
juvenile as compare to the aged tissues. Importantly,
our findings indicate that cells released from IVD
tissues exhibit distinct cellular morphologies and
molecular phenotypes (CD24, CD54, integrin a6,
CD239 and laminin a5) for NP cells. This new non-
enzymatic method for IVD cell isolation can be used to
acquire disc cells with a preserved phenotype, which
will be a useful tool for studying IVD cell biology
in vitro and exploring possibilities for IVD cellular
therapies.
CD24, a glycosylphosphatidylinostitol-anchored
cell surface protein that functions in differentiation
and activation of granulocytes and B lymphocytes
Fig. 4 Immunocytochemical staining for NP marker expression in IVD cells (NP, AF) derived from patients (6 and 68 yo). Bar 50 lm;
yo: year old. Images with higher magnification are presented as the insets in lower panels for NP cells
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(Nielsen et al. 1997), has been reported to be expressed
by NP cells of rat and human chordoma (a noto-
chordal-derived tumor) (Fujita et al. 2005). In our
previous study, we also confirmed the NP-specific
expression for CD24 in rat IVDs (Tang et al. 2012).
Here we further discovered that CD24 was strongly
expressed in juvenile human NP cells (6-year old)
through flow cytometry and immunocytochemical
staining, while no expression was detected in AF and
adult NP (68-year old) cells. Importantly, this finding
of a CD24 differential expression pattern with age
difference suggests that CD24 is an important maker
for young human NP cells. CD54 (ICAM-1) is a cell
surface glycoprotein expressed in a variety of cell
types including endothelial cells, activated leukocytes,
infiltrated macrophages (Vachula and Van Epps 1992;
Bevilacqua 1993). Previously, we found that human
IVD cells also expressed CD54 and its expression
could be up-regulated by proinflammatory cytokines
(IFN-c and TNF-a) (Gabr et al. 2011). In this study,
CD54 was expressed in both cultured human AF and
NP cells of all ages in vitro.
CD239, a receptor that binds exclusively to the
laminin a5 chain, and has been previously identified in
human red blood cells and as co-receptors in epithelia,
endothelia, smooth muscle cells and immature human
NP cells (Chen et al. 2009; Kikkawa and Miner 2005).
Positive immunocytochemical staining of CD239 was
observed in only young NP cells, which is consistent
with our previous study that demonstrated the expres-
sion pattern of CD239 and laminin a5 in immature
disc tissues (Chen et al. 2009). The finding of
expression for both laminin a5 chain and CD239 in
the immature NP, but not AF, regions points towards
the unique and distinctly different developmental
origins of the NP and AF (Rufai et al. 1995). These
expression patterns could be linked to notochordal
origin of the NP tissue based on the known involve-
ment of laminins in the basement membrane sur-
rounding notochord during differentiation (Parsons
et al. 2002). Our previous study also found that the
expression of a6 integrin subunit, another laminin
receptor, is associated with cells of the immature
porcine and human NP tissue (Chen et al. 2006; 2009;
Nettles et al. 2004), and that NP cell adhesion to
laminin-111 substrates is mediated by the a6 integrin
(Gilchrist et al. 2007). In this study, we further
confirmed distinct expression for the a6 subunit in
human NP cells by both flow cytometry analysis and
immunocytochemical staining. A similar region-spe-
cific expression pattern for laminin a5 (present for NP
cells, almost entirely absent in AF cells) was also
observed.
In summary, this new non-enzymatic tissue incu-
bation method for human IVD cell isolation is simple,
efficient, and preserves the molecular phenotype
(CD24, CD54, CD239, integrin a6 and laminin a5)
of NP cells. Cells isolated via this method may provide
a pure cell source for the study of disc degeneration
mechanisms, NP cell biology, and tissue engineering
and regeneration strategies.
Acknowledgments This study was supported by National
Institutes of Health (NIH) AR057410, AR047442 and
EB002263. We gratefully acknowledge Mr. Sun Bei for
assistance with cell culture and Dr. Christopher L. Gilchrist
for helpful discussion and manuscript review.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution, and reproduction in any medium, provided the
original author(s) and the source are credited.
References
Acosta FL Jr, Metz L, Adkisson HD, Liu J, Carruthers-Lie-
benberg E, Milliman C, Maloney M, Lotz JC (2011) Por-
cine intervertebral disc repair using allogeneic juvenile
articular chondrocytes or mesenchymal stem cells. Tissue
Eng Part A 17:3045–3055
Bevilacqua MP (1993) Endothelial-leukocyte adhesion mole-
cules. Annu Rev Immunol 11:767–804
Butler D, Trafimow JH, Andersson GB, McNeill TW, Huckman
MS (1990) Discs degenerate before facets. Spine (Phila Pa
1976) 15:111–113
Chen J, Baer AE, Paik PY, Yan W, Setton LA (2002) Matrix
protein gene expression in intervertebral disc cells sub-
jected to altered osmolarity. Biochem Biophys Res Com-
mun 293:932–938
Chen J, Yan W, Setton LA (2004) Static compression induces
zonal-specific changes in gene expression for extracellular
matrix and cytoskeletal proteins in intervertebral disc cells
in vitro. Matrix Biol 22:573–583
Chen J, Yan W, Setton LA (2006) Molecular phenotypes of
notochordal cells purified from immature nucleus pulpo-
sus. Eur Spine J 15:S303–S311
Chen J, Jing L, Gilchrist CL, Richardson WJ, Fitch RD et al (2009)
Expression of laminin isoforms, receptors, and binding pro-
teins unique to nucleus pulposus cells of immature interver-
tebral disc. Connect Tissue Res 50:294–306
Freemont AJ (2009) The cellular pathobiology of the degenerate
intervertebral disc and discogenic back pain. Rheumatol-
ogy (Oxford) 48:5–10
Cytotechnology (2014) 66:979–986 985
123
Fujita N, Miyamoto T, Imai J, Hosogane N, Suzuki T, Yagi M,
Morita K, Ninomiya K, Miyamoto K, Takaishi H, Mat-
sumoto M, Morioka H, Yabe H, Chiba K, Watanabe S,
Toyama Y, Suda T (2005) CD24 is expressed specifically
in the nucleus pulposus of intervertebral discs. Biochem
Biophys Res Commun 338:1890–1896
Gabr MA, Jing L, Helbling AR, Sinclair SM, Allen KD, Shamji
MF, Richardson WJ, Fitch RD, Setton LA, Chen J (2011)
Interleukin-17 synergizes with IFNgamma or TNFalpha to
promote inflammatory mediator release and intercellular
adhesion molecule-1 (ICAM-1) expression in human
intervertebral disc cells. J Orthop Res 29:1–7
Ganey T, Libera J, Moos V, Alasevic O, Fritsch KG, Meisel HJ,
Hutton WC (2003) Disc chondrocyte transplantation in a
canine model: a treatment for degenerated or damaged
intervertebral disc. Spine (Phila Pa 1976) 28:2609–2620
Gilchrist CL, Chen J, Richardson WJ, Loeser RF, Setton LA
(2007) Functional integrin subunits regulating cell-matrix
interactions in the intervertebral disc. J Orthop Res
25:829–840
Gruber HE, Johnson TL, Leslie K, Ingram JA, Martin D,
Hoelscher G, Banks D, Phieffer L, Coldham G, Hanley EN
Jr (2002) Autologous intervertebral disc cell implantation:
a model using Psammomys obesus, the sand rat. Spine
(Phila Pa 1976) 27:1626–1633
Huang YC, Leung VY, Lu WW, Luk KD (2013) The effects of
microenvironment in mesenchymal stem cell-based
regeneration of intervertebral disc. Spine J 13:352–362
Kikkawa Y, Miner JH (2005) Review: Lutheran/B-CAM: a
laminin receptor on red blood cells and in various tissues.
Connect Tissue Res 46:193–199
McCanless JD, Cole JA, Slack SM, Bumgardner JD, Zamora
PO, Haggard WO (2011) Modeling nucleus pulposus
regeneration in vitro: mesenchymal stem cells, alginate
beads, hypoxia, bone morphogenetic protein-2, and syn-
thetic peptide B2A. Spine (Phila Pa 1976) 36:2275–2285
Melrose J, Ghosh P, Taylor TK, Hall A, Osti OL, Vernon-
Roberts B, Fraser RD (1992) A longitudinal study of the
matrix changes induced in the intervertebral disc by sur-
gical damage to the annulus fibrosus. J Orthop Res
10:665–676
Nettles DL, Richardson WJ, Setton LA (2004) Integrin
expression in cells of the intervertebral disc. J Anat
204:515–520
Nielsen PJ, Lorenz B, Muller AM, Wenger RH, Brombacher F,
Simon M, von der Weid T, Langhorne WJ, Mossmann H,
Ko¨hler G (1997) Altered erythrocytes and a leaky block in
B-cell development in CD24/HSA-deficient mice. Blood
89:1058–1067
Parsons MJ, Pollard SM, Sau´de L, Feldman B, Coutinho P, Hirst
EM, Stemple DL (2002) Zebrafish mutants identify an
essential role for laminins in notochord formation. Devel-
opment 129:3137–3146
Risbud MV, Albert TJ, Guttapalli A, Vresilovic EJ, Hillibrand
AS, Vaccaro AR, Shapiro IM (2004) Differentiation of
mesenchymal stem cells towards a nucleus pulposus-like
phenotype in vitro: implications for cell-based transplan-
tation therapy. Spine (Phila Pa 1976) 29:2627–2632
Risbud MV, Guttapalli A, Tsai TT, Lee JY, Danielson KG,
Vaccaro AR, Albert TJ, Gazit Z, Gazit D, Shapiro IM
(2007) Evidence for skeletal progenitor cells in the
degenerate human intervertebral disc. Spine (Phila Pa
1976) 32:2537–2544
Rufai A, Benjamin M, Ralphs JR (1995) The development of
fibrocartilage in the rat intervertebral disc. Anat Embryol
(Berl) 192:53–62
Sakai D, Mochida J, Yamamoto Y, Nomura T, Okuma M, Ni-
shimura K, Nakai T, Ando K, Hotta T (2003) Transplan-
tation of mesenchymal stem cells embedded in
Atelocollagen gel to the intervertebral disc: a potential
therapeutic model for disc degeneration. Biomaterials
24:3531–3541
Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K,
Hotta T (2005) Differentiation of mesenchymal stem cells
transplanted to a rabbit degenerative disc model: potential
and limitations for stem cell therapy in disc regeneration.
Spine (Phila Pa 1976) 30:2379–2387
Sakai D, Nakamura Y, Nakai T, Mishima T, Kato S, Grad S,
Alini M, Risbud MV, Chan D, Cheah KS, Yamamura K,
Masuda K, Okano H, Ando K, Mochida J (2012) Exhaus-
tion of nucleus pulposus progenitor cells with ageing and
degeneration of the intervertebral disc. Nat Commun
3:1264
Smith JW, Walmsley R (1951) Experimental incision of the
intervertebral disc. J Bone Joint Surg Br 33-B:612–625
Smith LJ, Nerurkar NL, Choi KS, Harfe BD, Elliott DM (2011)
Degeneration and regeneration of the intervertebral disc:
lessons from development. Dis Model Mech 4:31–41
Tang X, Jing L, Chen J (2012) Changes in the molecular phe-
notype of nucleus pulposus cells with intervertebral disc
aging. PLoS One 7:e52020
Urban JP, McMullin JF (1985) Swelling pressure of the iner-
vertebral disc: influence of proteoglycan and collagen
contents. Biorheology 22:145–157
Urban JP, Roberts S (2003) Degeneration of the intervertebral
disc. Arthritis Res Ther 5:120–130
Vachula M, Van Epps DE (1992) In vitro models of lymphocyte
transendothelial migration. Invasion Metastasis 12:66–81
Wang JY, Baer AE, Kraus VB, Setton LA (2001) Intervertebral
disc cells exhibit differences in gene expression in alginate
and monolayer culture. Spine (Phila Pa 1976)
26:1747–1751 (discussion 1752)
Weiler C, Nerlich AG, Schaaf R, Bachmeier BE, Wuertz K,
Boos N (2010) Immunohistochemical identification of
notochordal markers in cells in the aging human lumbar
intervertebral disc. Eur Spine J 19:1761–1770
Yoshikawa T, Ueda Y, Miyazaki K, Koizumi M, Takakura Y
(2010) Disc regeneration therapy using marrow mesen-
chymal cell transplantation: a report of two case studies.
Spine (Phila Pa 1976) 35:E475–E480
Zhao CQ, Wang LM, Jiang LS, Dai LY (2007) The cell biology
of intervertebral disc aging and degeneration. Ageing Res
Rev 6:247–261
986 Cytotechnology (2014) 66:979–986
123
